Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer (TOP0706)

Clinical Trial ID NCT00564876

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00564876

Top papers